IMMUNITYBIO, INC. Shares Outstanding (Cover Page)
IMMUNITYBIO, INC. (IBRX) had Shares Outstanding (Cover Page) of 1.06 billion shares as of 2026-07-31, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-04
- 2026-07-31: Entity Common Stock, Shares Outstanding 1.06B shares.
- 2026-05-05: Entity Common Stock, Shares Outstanding 1.05B shares.
- 2026-02-19: Entity Common Stock, Shares Outstanding 1.03B shares.
- 2025-10-30: Entity Common Stock, Shares Outstanding 984.97M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 1.06B shares 10-Q · filed 2026-08-04 |
| 2026-05-05 | 1.05B shares 10-Q · filed 2026-05-07 |
| 2026-02-19 | 1.03B shares 10-K · filed 2026-02-23 |
| 2025-10-30 | 984.97M shares 10-Q · filed 2025-11-05 |
| 2025-07-31 | 945.25M shares 10-Q · filed 2025-08-05 |
| 2025-05-08 | 882.62M shares 10-Q · filed 2025-05-12 |
| 2025-02-27 | 853.44M shares 10-K · filed 2025-03-03 |
| 2024-11-08 | 696.83M shares 10-Q · filed 2024-11-12 |
| 2024-08-07 | 696.53M shares 10-Q · filed 2024-08-12 |
| 2024-05-03 | 691.57M shares 10-Q · filed 2024-05-09 |
| 2024-03-14 | 673.95M shares 10-K · filed 2024-03-19 |
| 2023-11-03 | 667.71M shares 10-Q · filed 2023-11-09 |
| 2023-08-04 | 456.25M shares 10-Q · filed 2023-08-08 |
| 2023-05-05 | 435.98M shares 10-Q · filed 2023-05-11 |
| 2023-02-24 | 435.84M shares 10-K · filed 2023-03-01 |
| 2022-11-04 | 400.30M shares 10-Q · filed 2022-11-09 |
| 2022-08-04 | 400.30M shares 10-Q · filed 2022-08-08 |
| 2022-05-05 | 397.96M shares 10-Q · filed 2022-05-10 |
| 2022-02-24 | 397.91M shares 10-K · filed 2022-03-01 |
| 2021-11-10 | 397.59M shares 10-Q · filed 2021-11-12 |
| 2021-08-10 | 391.16M shares 10-Q · filed 2021-08-12 |
| 2021-05-12 | 383.91M shares 10-Q · filed 2021-05-14 |
| 2021-03-03 | 109.34M shares 10-K · filed 2021-03-04 |
| 2020-11-05 | 108.59M shares 10-Q · filed 2020-11-09 |
| 2020-08-05 | 107.97M shares 10-Q · filed 2020-08-07 |
| 2020-05-08 | 98.51M shares 10-Q · filed 2020-05-11 |
| 2020-03-20 | 98.48M shares 10-K · filed 2020-03-25 |
| 2019-11-01 | 98.37M shares 10-Q · filed 2019-11-05 |
| 2019-08-02 | 98.31M shares 10-Q · filed 2019-08-06 |
| 2019-05-03 | 98.67M shares 10-Q · filed 2019-05-08 |
| 2019-03-08 | 79.09M shares 10-K · filed 2019-03-13 |
| 2018-11-05 | 79.23M shares 10-Q · filed 2018-11-07 |
| 2018-08-02 | 79.21M shares 10-Q · filed 2018-08-06 |
| 2018-05-03 | 78.09M shares 10-Q · filed 2018-05-07 |
| 2018-03-07 | 79.03M shares 10-K · filed 2018-03-12 |
| 2017-10-31 | 79.46M shares 10-Q · filed 2017-11-07 |
| 2017-08-01 | 79.44M shares 10-Q · filed 2017-08-07 |
| 2017-05-03 | 82.16M shares 10-Q · filed 2017-05-08 |
| 2017-03-10 | 82.30M shares 10-K · filed 2017-03-15 |
| 2016-11-03 | 82.38M shares 10-Q · filed 2016-11-10 |
| 2016-08-09 | 82.31M shares 10-Q · filed 2016-08-15 |
| 2016-05-10 | 81.98M shares 10-Q · filed 2016-05-16 |
| 2016-03-25 | 81.93M shares 10-K · filed 2016-03-30 |
| 2015-10-31 | 81.22M shares 10-Q · filed 2015-11-12 |
| 2015-08-31 | 81.14M shares 10-Q · filed 2015-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |